• DOI:10.1080/13543784.2016.1175432
Corpus ID: 20858344

Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia

@article{Przespolewski2016InhibitorsOL,
  title={Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia},
  author={Amanda Przespolewski and E. Wang},
  journal={Expert Opinion on Investigational Drugs},
  year={2016},
  volume={25},
  pages={771 - 780}
}

Amanda Przespolewski, E. Wang

Published 2016

Biology, Medicine

Expert Opinion on Investigational Drugs

ABSTRACT Introduction: Epigenetic dysregulation plays a critical role in the pathogenesis of acute myeloid leukemia (AML). Alterations in histone methylation lead to aberrant silencing of expression of multiple genes involved in tumor suppression and cell cycling, resulting in myeloid maturation arrest and proliferation of early myeloid progenitors. One promising approach targeting chromatin regulatory proteins is inhibition of lysine specific demethylase-1 (LSD1), an enzyme responsible for… CONTINUE READING

View on Taylor & Francis

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed